
Dr Matthew Partridge
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
Latest articles by Dr Matthew Partridge
-
Microsoft’s partnership with OpenAI is on the rocks
Microsoft’s joint venture with OpenAI, the developer of ChatGPT, appears to be in trouble. What now for the two groups?
By Dr Matthew Partridge Published
-
Carson Block on short-selling and what investors should watch out for when going long
Interview Renowned short seller Carson Block talks to Matthew Partridge about his specialism and where to go long
By Dr Matthew Partridge Published
Interview -
26 June 1906: The first Grand Prix
The first 'proper' Grand Prix on closed public roads was held by the Automobile Club de France (ACF), on this day in June 1906.
By Dr Matthew Partridge Last updated
-
Halma reaches new all-time high
Profits at Halma, one of Britain’s best blue chips, have hit a new record. But could US tariffs now cloud the outlook?
By Dr Matthew Partridge Published
-
Airtel Africa is dialling the right numbers – should you buy?
Opinion Mobile phone services group Airtel Africa is inexpensive and growing fast
By Dr Matthew Partridge Published
Opinion -
The British railway industry is in rude health – here's why investors should jump aboard
The railway industry has bounced back from the devastating impact of the pandemic and is entering a new phase of development – and profitability
By Dr Matthew Partridge Published
-
Infrastructure investing: a haven of stable growth amid market turmoil
From booming construction in emerging markets to digital and green transitions, the infrastructure sector offers security, returns and long-term opportunities
By Dr Matthew Partridge Published
-
5 June 1933: The US dollar is unshackled from gold
Features On this day in 1933, US president Franklin D Roosevelt banned gold from being used as a method of payment in private contracts.
By Dr Matthew Partridge Last updated
Features -
Review: Gilpin Hotel & Lake House – a luxury stay in the Lake District
Travel Gilpin Hotel & Lake House near Windermere is a treat for the senses, says Matthew Partridge
By Dr Matthew Partridge Published
Travel -
23 May 1934: Bonnie and Clyde killed in ambush
Bonnie Parker and Clyde Barrow became infamous in the 1930s for robbing banks. But their notoriety ultimately proved their undoing.
By Dr Matthew Partridge Last updated
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?
Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
By Dr Matthew Partridge Published
-
Review: Buckland Manor – a quiet stay in the Cotswolds
Travel Buckland Manor is a true gem in the Cotswolds, hidden away from the crowds, says Matthew Partridge
By Dr Matthew Partridge Published
Travel -
Precision-engineered profits: How to invest in genomics
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals. Smart investors should buy in now, says Matthew Partridge
By Dr Matthew Partridge Published
-
Tesco braces for supermarket price war with rival Asda
Tesco, Britain’s biggest grocer, has opted to cut its prices more quickly to prevent Asda grabbing market share
By Dr Matthew Partridge Published
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
3 April 1948: Marshall Plan signed into law
Features On this day in 1948, Secretary of State George Marshall’s European Recovery Program, otherwise known as the Marshall Plan, is adopted.
By Dr Matthew Partridge Last updated
Features -
10 April 1912: the Titanic sets sail on its doomed maiden voyage
Features On this day in 1912 the White Star line's 'unsinkable' liner, the RMS Titanic, left Southampton on its doomed maiden voyage.
By Dr Matthew Partridge Last updated
Features -
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
IonQ offers no quantum of solace
Opinion Quantum computing group IonQ is inefficient, overhyped and overpriced
By Dr Matthew Partridge Published
Opinion -
How to invest in weight-loss drugs
The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
By Dr Matthew Partridge Published
-
Boots parent company Walgreens sold to private equity firm
US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?
By Dr Matthew Partridge Published
-
How Corpay is cashing in on expenses
Financial technology company Corpay has found a profitable niche managing corporate payments
By Dr Matthew Partridge Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published